Company Profile
Wuhan Newbio Pharm-Tech Co., Ltd., founded in 2015, is specialized manufacturer and supplier of Pharmaceutical Raw Materials and Pharmaceutical Intermediates. The company engages in pharmaceuticals R&D, production and sales. Our main products are Antibiotics, Small-molecule APIs, Novel Compounds, Fine Chemicals etc.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
Cisplatin |
Platinum,diamminedichloro-,(SP-4-2)-;Platinum,diamminedichloro-,cis-;(SP-4-2)-Diamminedichloroplatinum;cis-Diamminedichloroplatinum;cis-Dichlorodiamineplatinum(II);cis-Platinum(II) diaminodichloride;cis-Platinum(II) diamminedichloride;cis-Dichlorodiammineplatinum;cis-Platinous diaminodichloride;cis-Platinum diaminodichloride;cis-Platinumdiammine dichloride;cis-Platinumdiamine dichloride;cis-Diaminodichloroplatinum(II);NSC 119875;Cisplatin;cis-Platinum II;Platinol;Neoplatin;cis-Platine;Biocisplatinum;cis-DDP;cis-Diamminedichloroplatinum(II);Platidiam;cis-Platinum;Cisplatinum;CPDD;cis-Platin;cis-Dichlorodiammineplatinum(II);TR 170;CDDP;DDP;CPPD;cis-Diaminedichloroplatinum(II);Cisplatyl;Briplatin;DDP (antitumor agent);Abiplatin;SPI 077;CACP;Lederplatin;Platosin;Platamine;Platiblastin;Platistin;Platinoxan;CPDC;Cismaplat;Citoplatino;Rand;Platinex;Platinol AQ;SPI 077 (complex);SPI 077B103;Cisplatino;Lipoplatin;Randa;Fauldiscipla;IA-call;CP Ethypharm;LiPlaCis;Cisplatine Mylan;Kemoplat;Citoplax;Maruko;cis-Diaminedichloridoplatinum(II);cis-Diammineplatinum(II);96081-74-2;936542-99-3 |
15663-27-1 | - / 99.6% | Inquiry |
Crizotinib |
2-Pyridinamine,3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-;3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine;[3-[[(R)-1-(2,6-Dichloro-3-fluorophenyl)ethyl]oxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-yl]amine;PF 2341066;PF 02341066;Crizotinib;(R)-3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-ylamine;Xalkori;3-((R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine;912279-98-2 |
877399-52-5 | - / 99.6% | Inquiry |
Erlotinib Hydrochloride |
4-Quinazolinamine,N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-,hydrochloride (1:1);4-Quinazolinamine,N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-,monohydrochloride;CP 358774;OSI 774;Tarceva;6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride;[6,7-Bis(2-methoxyethoxy)quinazolin-4-yl]-(3-ethynylphenyl)amine hydrochloride;Erlotinib hydrochloride |
183319-69-9 | - / 99.6% | Inquiry |
Methotrexate |
METHOTREXATEFORINJECTION;sodium 4-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]am ino]-5-hydroxy-5-oxo-pentanoate;METHOTREXATE(N-(4-(((2,4-DIAMINO-6-PTERIDINYL)METHYLAMINO)BENZOYL)-L-GLUTAMICACID);4-Amino-N10-methylfolic acid;Glutamic acid, N-[p-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-, L-(+)- (8CI);L-Glutamic acid, N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]- (9CI);L-Methotrexate;Methotrexat-Ebewe |
59-05-2 | - / 99.6% | Inquiry |
Oxaliplatin |
Platinum,[rel-(1R,2R)-1,2-cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]-,(SP-4-2)-;Platinum,(1,2-cyclohexanediamine-N,N′)[ethanedioato(2-)-O,O′]-,[SP-4-2-(trans)]-;Platinum,[rel-(1R,2R)-1,2-cyclohexanediamine-κN,κN′][ethanedioato(2-)-κO1,κO2]-,(SP-4-2)-;1,2-Cyclohexanediamine,platinum complex,trans-;(SP-4-2)-[rel-(1R,2R)-1,2-Cyclohexanediamine-κN1,κN2][ethanedioato(2-)-κO1,κO2]platinum;NSC 271670;ACT 078 |
63121-00-6 | - / 99.6% | Inquiry |
Repaglinide |
Benzoic acid,2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]-;Benzoic acid,2-ethoxy-4-[2-[[3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]-,(S)-;2-Ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic acid;Repaglinide;AG-EE 623ZW;Prandin;NovoNorm;(S)-(+)-2-Ethoxy-4-[[[N-[1-(2-piperidinophenyl)-3-methylbutyl]amino]carbonyl]methyl]benzoic acid;AGEE 623;Novolon;Eurepa;(S)-(+)-Repaglinide;GlucoNorm;Europa 0.5;Europa 1;(S)-2-Ethoxy-4-[2-[[3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2-oxoethyl]benzoic acid;Enyglid |
135062-02-1 | - / 99.6% | Inquiry |
Tofacitinib |
1-Piperidinepropanenitrile,4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-,(3R,4R)-;3-Piperidinamine,1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-,(3R,4R)-;(3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile;CP 690550;Tofacitinib;2097815-04-6 |
477600-75-2 | - / 99.6% | Inquiry |
Tofacitinib Citrate |
1-Piperidinepropanenitrile,4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-,(3R,4R)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1);3-Piperidinamine,1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-,(3R,4R)-,2-hydroxy-1,2,3-propanetricarboxylate (1:1);Tasocitinib citrate;CP 690500-10;Tofacitinib citrate;CP 690550-10;Xeljanz;Xeljanz XR |
540737-29-9 | - / 99.6% | Inquiry |
CONTACT INFORMATION
Sign In for Details